ZNF671, or Zinc Finger Protein 671, is a member of the Krüppel C2H2-type zinc-finger protein family. This family is known for its roles in DNA binding and gene expression regulation, and members are often involved in a variety of biological processes, including development, differentiation, and cell proliferation. ZNF671, specifically, is implicated in the regulation of transcriptional processes by binding to DNA at specific gene sites, thereby influencing the expression of genes that are critical for various cellular functions. This regulatory activity is essential for maintaining normal cellular homeostasis and ensuring proper cellular responses to developmental and environmental signals.
The inhibition of ZNF671 can occur through several mechanisms that disrupt its function or expression, impacting its role in gene regulation. One common method of inhibiting the function of ZNF671 involves interfering with its ability to bind DNA. This can be achieved through the binding of molecules that competitively inhibit ZNF671's interaction with its DNA targets, thereby preventing it from exerting its regulatory effects on gene expression. Additionally, modifications to the protein structure of ZNF671, such as phosphorylation, methylation, or acetylation, can alter its DNA-binding affinity or stability, impacting its regulatory functions. Furthermore, the expression of ZNF671 itself can be downregulated at the transcriptional level, through mechanisms such as RNA interference or the action of repressive transcription factors, which decrease the overall levels of ZNF671 protein available in the cell. This reduction in protein levels can lead to diminished regulation of target genes, affecting the cellular processes that depend on the proper function of ZNF671. These inhibitory mechanisms are crucial for the fine-tuning of gene expression and the maintenance of cellular function, providing potential targets for modulating the activity of ZNF671 in research and biotechnology contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits the positive transcription elongation factor b (P-TEFb), impacting transcriptional elongation where ZNF671 may be functional. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Inhibits RNA polymerase II, affecting transcription events where ZNF671 might exert its regulatory role. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Targets BET bromodomains, which can affect transcription regulation, subsequently modulating pathways where ZNF671 might be involved. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Spliceosome inhibitor that can influence RNA splicing processes, altering ZNF671 function indirectly. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor that could influence pathways, particularly signaling pathways, that modulate or are modulated by ZNF671. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
CDK9 inhibitor that can inhibit transcription elongation and potentially affect regions where ZNF671 is operational. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, affecting DNA supercoiling and indirectly influencing ZNF671 DNA-binding. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with the DNA transcription mechanism, influencing ZNF671 by blocking its interaction with DNA templates. | ||||||
SNS-032 | 345627-80-7 | sc-364621 sc-364621A | 5 mg 10 mg | $169.00 $262.00 | ||
A CDK inhibitor that can interfere with the cell cycle and transcriptional processes, where ZNF671 may function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor affecting protein turnover and stability, indirectly affecting ZNF671's functionality within cellular processes. | ||||||